• Explore /
  • Poster
  • / Predictor: Randomized phase II study of preoperative afatinib in untreated nonmetastatic head and neck squamous cell carcinoma patients (HNSCC) aiming at identifying predictive and pharmacodynamic biomarkers of efficacy.

Predictor: Randomized phase II study of preoperative afatinib in untreated nonmetastatic head and neck squamous cell carcinoma patients (HNSCC) aiming at identifying predictive and pharmacodynamic biomarkers of efficacy.

Abstract Poster

Authors

null

Christophe Le Tourneau

Department of Medical Oncology, Institut Curie, Paris, France

Christophe Le Tourneau , Jean-Pierre Delord , Gilles Dolivet , Olivier Capitain , Laurent Laccourreye , Jerome Fayette , Dominique De Raucourt , Frederic Peyrade , Olivier Malard , Frederic Rolland , Christine Orsini , Odette Mariani , Jerzy Klijanienko , Leanne de Koning , Ivan Bieche , Xavier Sastre , Nicolas Aide , Xavier Paoletti , Stéphane Temam

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Head and Neck Cancer

Clinical Trial Registration Number

NCT01415674

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr TPS6105)

DOI

10.1200/jco.2014.32.15_suppl.tps6105

Abstract #

TPS6105

Poster Bd #

136A

Abstract Disclosures

Similar Posters

First Author: Christophe Le Tourneau

First Author: Melissa Austin

First Author: Zhigong Wei

First Author: Min Hee Hong